Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine Dosing for Oxytocin-Induced Hypotension in Cesarean Section
NCT07420127Phase 4Recruiting
- Sponsor
- Rawalpindi Medical University
- Start
- Feb 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of phenylephrine in hypotension (2 arms), sponsored by Rawalpindi Medical University. Primary endpoint: Number of Hypotensive episodes at 10 minutes. Started Feb 2026; status: recruiting.
02
Drugs
phenylephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT07420127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07420127.